DIRS.INFO top alerts submit data jurnalism about API
login
Top related persons:
Mike Lenz - 1 MicroStrategy - 1 Tesla - 1 Rivian - 1 Goldman - 1 OneSpaWorld - 1 Walt Disney - 1 Needham - 1
Top related locs:
Brooklyn New York City bitcoin Netherlands
Top related orgs:
Federal Trade Commission - 1 Amazon - 1 FedEx - 1 Securities and Exchange Commission - 1 Barclays - 1 GlaxoSmithKline — - 1 Petrobras — - 1 Walt Disney — - 1

Search resuls for: "GlaxoSmithKline —"


2 mentions found


☆ Stocks making the biggest moves midday: Dollar Tree, Amazon, FedEx and more
  + stars: | 2023-06-21 | by ( Alex Harring | ) www.cnbc.com   time to read: +4 min
People walk by a Dollar Tree store on December 11, 2018 in the Brooklyn borough of New York City. FedEx — The delivery company fell 1.7% after quarterly revenue missed expectations and announced CFO Mike Lenz would retire on July 31. Adjusted earnings were better than expected at $4.94 per share against the anticipated $4.89, while forward guidance was around flat. Advanced Micro Devices — Shares of the chipmaker pulled back nearly 5%, on track for their biggest intraday loss in two weeks. Dollar Tree — Shares of Dollar Tree popped more than 3% after the discount retailer reiterated its fiscal second-quarter 2023 earnings guidance.
Persons: Mike Lenz, MicroStrategy, Tesla, Rivian, Goldman, OneSpaWorld, Walt Disney, Needham, Laura Martin, Bob Iger, Raymond James, Uniqure, hemophilia, Yun Li, Michelle Fox, Jesse Pound, Sarah Min, Brian Evans Organizations: Federal Trade Commission, Amazon, FedEx, Securities and Exchange Commission, Barclays, GlaxoSmithKline —, Petrobras —, Walt Disney —, AMD Locations: Brooklyn, New York City, bitcoin, Netherlands
☆ Why isn’t there an RSV vaccine for kids?
  + stars: | 2022-10-26 | by ( Https | Media-Cldnry.S-Nbcnews.Com Image Upload Newscms Berkeley-Lovelace-Jr.Jpg | Berkeley Lovelace Jr. | ) www.nbcnews.com   time to read: +4 min
That there is no RSV vaccine for kids is not for lack of interest, experts say. But a trial gone wrong many years ago and a tricky target protein have made developing an RSV vaccine difficult. Researchers’ attempts to develop an RSV vaccine go back decades, according to Dr. Ofer Levy, the director of the Precision Vaccines Program at Boston Children's Hospital. In August, Pfizer announced that its experimental RSV vaccine was nearly 86% effective in preventing severe illness in adults ages 60 and older. GSK, however, said it abandoned its efforts last year to develop a pediatric RSV vaccine, because trials suggested it wasn't effective.
0 next >>
Total: 2